Biosynex (ALBIO) — Financial Flexibility Index
Biosynex (ALBIO) has a Financial Flexibility Index of -0.05x as of June 2025. Free cash flow of €-5.49 Million (operating CF €-7.07 Million minus capex €1.58 Million) represents 0% of total liabilities (€105.13 Million). Check ALBIO strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Biosynex Financial Flexibility Index (2008–2024)
Historical Financial Flexibility Index trend for Biosynex across 12 annual periods. See working capital position of Biosynex to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Biosynex (2008–2024)
Year-by-year free cash flow to debt coverage for Biosynex. For the full company profile including market capitalisation, see Biosynex (ALBIO) total market value.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.05x | €-5.28 Million | €-10.12 Million | €114.19 Million | ▼ -118.2% |
| 2023 | 0.25x | €29.89 Million | €-9.65 Million | €117.41 Million | ▼ -32.3% |
| 2022 | 0.38x | €35.03 Million | €4.95 Million | €93.21 Million | ▼ -70.5% |
| 2021 | 1.27x | €128.85 Million | €109.83 Million | €101.14 Million | ▲ +86.9% |
| 2020 | 0.68x | €40.75 Million | €31.64 Million | €59.78 Million | ▲ +13.2% |
| 2019 | 0.60x | €10.22 Million | €1.10 Million | €16.97 Million | ▼ -35.9% |
| 2018 | 0.94x | €9.58 Million | €467.12K | €10.20 Million | ▲ +13.6% |
| 2017 | 0.83x | €9.60 Million | €484.82K | €11.60 Million | ▲ +2458.3% |
| 2016 | 0.03x | €489.91K | €489.91K | €15.15 Million | ▼ -52.2% |
| 2015 | 0.07x | €461.66K | €461.66K | €6.82 Million | ▼ -45.2% |
| 2009 | 0.12x | €119.33K | €72.40K | €965.95K | ▲ +156.0% |
| 2008 | -0.22x | €-161.13K | €-184.44K | €731.01K | — |